Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of recombinant glycoprotein E herpes zoster vaccine in adults aged 50 years and older
2008-000367-42Phase 3Terminated
- Sponsor
- GSK
- Start
- Jun 2010
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in herpes zoster (HZ) comparing gE/AS01B vaccine with Placebo (2 arms). Primary endpoints: Confirmed cases of herpes zoster and Age-stratified vaccine efficacy against herpes zoster. Started Jun 2010; status: terminated.
02
Drugs
zoster vaccine recombinant, adjuvanted
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on 2008-000367-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000367-42.